Global Angiogenesis Modulators Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Angiogenesis Modulators will have significant change from previous year. According to our (LP Information) latest study, the global Angiogenesis Modulators market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Angiogenesis Modulators market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Angiogenesis Modulators market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angiogenesis Modulators market, reaching US$ million by the year 2028. As for the Europe Angiogenesis Modulators landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Angiogenesis Modulators players cover Celgene Corporation (USA), Eisai (Japan), Amgen, Inc. (USA), and Genentech, Inc. (USA), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiogenesis Modulators market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Angiogenesis Modulators will have significant change from previous year. According to our (LP Information) latest study, the global Angiogenesis Modulators market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Angiogenesis Modulators market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Angiogenesis Modulators market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angiogenesis Modulators market, reaching US$ million by the year 2028. As for the Europe Angiogenesis Modulators landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Angiogenesis Modulators players cover Celgene Corporation (USA), Eisai (Japan), Amgen, Inc. (USA), and Genentech, Inc. (USA), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiogenesis Modulators market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Angiogenesis Inhibitors
- Angiogenesis Stimulators
- Angiogenin
- Others
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Celgene Corporation (USA)
- Eisai (Japan)
- Amgen, Inc. (USA)
- Genentech, Inc. (USA)
- GlaxoSmithKline plc (UK)
- Bayer Pharma AG (Germany)
- Bionomics Ltd. (Australia)
- CASI Pharmaceuticals, Inc. (USA)
- AstraZeneca plc (UK)
- Eli Lilly and Company (USA)
- F.Hoffmann-La Roche AG (Switzerland)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angiogenesis Modulators Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Angiogenesis Modulators by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Angiogenesis Modulators by Country/Region, 2017, 2022 & 2028
2.2 Angiogenesis Modulators Segment by Type
2.2.1 Angiogenesis Inhibitors
2.2.2 Angiogenesis Stimulators
2.2.3 Angiogenin
2.2.4 Others
2.3 Angiogenesis Modulators Sales by Type
2.3.1 Global Angiogenesis Modulators Sales Market Share by Type (2017-2022)
2.3.2 Global Angiogenesis Modulators Revenue and Market Share by Type (2017-2022)
2.3.3 Global Angiogenesis Modulators Sale Price by Type (2017-2022)
2.4 Angiogenesis Modulators Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Lung Cancer
2.4.4 Prostate Cancer
2.4.5 Others
2.5 Angiogenesis Modulators Sales by Application
2.5.1 Global Angiogenesis Modulators Sale Market Share by Application (2017-2022)
2.5.2 Global Angiogenesis Modulators Revenue and Market Share by Application (2017-2022)
2.5.3 Global Angiogenesis Modulators Sale Price by Application (2017-2022)
3 GLOBAL ANGIOGENESIS MODULATORS BY COMPANY
3.1 Global Angiogenesis Modulators Breakdown Data by Company
3.1.1 Global Angiogenesis Modulators Annual Sales by Company (2020-2022)
3.1.2 Global Angiogenesis Modulators Sales Market Share by Company (2020-2022)
3.2 Global Angiogenesis Modulators Annual Revenue by Company (2020-2022)
3.2.1 Global Angiogenesis Modulators Revenue by Company (2020-2022)
3.2.2 Global Angiogenesis Modulators Revenue Market Share by Company (2020-2022)
3.3 Global Angiogenesis Modulators Sale Price by Company
3.4 Key Manufacturers Angiogenesis Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiogenesis Modulators Product Location Distribution
3.4.2 Players Angiogenesis Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANGIOGENESIS MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Angiogenesis Modulators Market Size by Geographic Region (2017-2022)
4.1.1 Global Angiogenesis Modulators Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Angiogenesis Modulators Annual Revenue by Geographic Region
4.2 World Historic Angiogenesis Modulators Market Size by Country/Region (2017-2022)
4.2.1 Global Angiogenesis Modulators Annual Sales by Country/Region (2017-2022)
4.2.2 Global Angiogenesis Modulators Annual Revenue by Country/Region
4.3 Americas Angiogenesis Modulators Sales Growth
4.4 APAC Angiogenesis Modulators Sales Growth
4.5 Europe Angiogenesis Modulators Sales Growth
4.6 Middle East & Africa Angiogenesis Modulators Sales Growth
5 AMERICAS
5.1 Americas Angiogenesis Modulators Sales by Country
5.1.1 Americas Angiogenesis Modulators Sales by Country (2017-2022)
5.1.2 Americas Angiogenesis Modulators Revenue by Country (2017-2022)
5.2 Americas Angiogenesis Modulators Sales by Type
5.3 Americas Angiogenesis Modulators Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiogenesis Modulators Sales by Region
6.1.1 APAC Angiogenesis Modulators Sales by Region (2017-2022)
6.1.2 APAC Angiogenesis Modulators Revenue by Region (2017-2022)
6.2 APAC Angiogenesis Modulators Sales by Type
6.3 APAC Angiogenesis Modulators Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Angiogenesis Modulators by Country
7.1.1 Europe Angiogenesis Modulators Sales by Country (2017-2022)
7.1.2 Europe Angiogenesis Modulators Revenue by Country (2017-2022)
7.2 Europe Angiogenesis Modulators Sales by Type
7.3 Europe Angiogenesis Modulators Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angiogenesis Modulators by Country
8.1.1 Middle East & Africa Angiogenesis Modulators Sales by Country (2017-2022)
8.1.2 Middle East & Africa Angiogenesis Modulators Revenue by Country (2017-2022)
8.2 Middle East & Africa Angiogenesis Modulators Sales by Type
8.3 Middle East & Africa Angiogenesis Modulators Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiogenesis Modulators
10.3 Manufacturing Process Analysis of Angiogenesis Modulators
10.4 Industry Chain Structure of Angiogenesis Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiogenesis Modulators Distributors
11.3 Angiogenesis Modulators Customer
12 WORLD FORECAST REVIEW FOR ANGIOGENESIS MODULATORS BY GEOGRAPHIC REGION
12.1 Global Angiogenesis Modulators Market Size Forecast by Region
12.1.1 Global Angiogenesis Modulators Forecast by Region (2023-2028)
12.1.2 Global Angiogenesis Modulators Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiogenesis Modulators Forecast by Type
12.7 Global Angiogenesis Modulators Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Celgene Corporation (USA)
13.1.1 Celgene Corporation (USA) Company Information
13.1.2 Celgene Corporation (USA) Angiogenesis Modulators Product Offered
13.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Celgene Corporation (USA) Main Business Overview
13.1.5 Celgene Corporation (USA) Latest Developments
13.2 Eisai (Japan)
13.2.1 Eisai (Japan) Company Information
13.2.2 Eisai (Japan) Angiogenesis Modulators Product Offered
13.2.3 Eisai (Japan) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eisai (Japan) Main Business Overview
13.2.5 Eisai (Japan) Latest Developments
13.3 Amgen, Inc. (USA)
13.3.1 Amgen, Inc. (USA) Company Information
13.3.2 Amgen, Inc. (USA) Angiogenesis Modulators Product Offered
13.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Amgen, Inc. (USA) Main Business Overview
13.3.5 Amgen, Inc. (USA) Latest Developments
13.4 Genentech, Inc. (USA)
13.4.1 Genentech, Inc. (USA) Company Information
13.4.2 Genentech, Inc. (USA) Angiogenesis Modulators Product Offered
13.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Genentech, Inc. (USA) Main Business Overview
13.4.5 Genentech, Inc. (USA) Latest Developments
13.5 GlaxoSmithKline plc (UK)
13.5.1 GlaxoSmithKline plc (UK) Company Information
13.5.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Offered
13.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline plc (UK) Main Business Overview
13.5.5 GlaxoSmithKline plc (UK) Latest Developments
13.6 Bayer Pharma AG (Germany)
13.6.1 Bayer Pharma AG (Germany) Company Information
13.6.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Offered
13.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bayer Pharma AG (Germany) Main Business Overview
13.6.5 Bayer Pharma AG (Germany) Latest Developments
13.7 Bionomics Ltd. (Australia)
13.7.1 Bionomics Ltd. (Australia) Company Information
13.7.2 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Offered
13.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bionomics Ltd. (Australia) Main Business Overview
13.7.5 Bionomics Ltd. (Australia) Latest Developments
13.8 CASI Pharmaceuticals, Inc. (USA)
13.8.1 CASI Pharmaceuticals, Inc. (USA) Company Information
13.8.2 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Offered
13.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CASI Pharmaceuticals, Inc. (USA) Main Business Overview
13.8.5 CASI Pharmaceuticals, Inc. (USA) Latest Developments
13.9 AstraZeneca plc (UK)
13.9.1 AstraZeneca plc (UK) Company Information
13.9.2 AstraZeneca plc (UK) Angiogenesis Modulators Product Offered
13.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AstraZeneca plc (UK) Main Business Overview
13.9.5 AstraZeneca plc (UK) Latest Developments
13.10 Eli Lilly and Company (USA)
13.10.1 Eli Lilly and Company (USA) Company Information
13.10.2 Eli Lilly and Company (USA) Angiogenesis Modulators Product Offered
13.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eli Lilly and Company (USA) Main Business Overview
13.10.5 Eli Lilly and Company (USA) Latest Developments
13.11 F.Hoffmann-La Roche AG (Switzerland)
13.11.1 F.Hoffmann-La Roche AG (Switzerland) Company Information
13.11.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Offered
13.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 F.Hoffmann-La Roche AG (Switzerland) Main Business Overview
13.11.5 F.Hoffmann-La Roche AG (Switzerland) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angiogenesis Modulators Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Angiogenesis Modulators by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Angiogenesis Modulators by Country/Region, 2017, 2022 & 2028
2.2 Angiogenesis Modulators Segment by Type
2.2.1 Angiogenesis Inhibitors
2.2.2 Angiogenesis Stimulators
2.2.3 Angiogenin
2.2.4 Others
2.3 Angiogenesis Modulators Sales by Type
2.3.1 Global Angiogenesis Modulators Sales Market Share by Type (2017-2022)
2.3.2 Global Angiogenesis Modulators Revenue and Market Share by Type (2017-2022)
2.3.3 Global Angiogenesis Modulators Sale Price by Type (2017-2022)
2.4 Angiogenesis Modulators Segment by Application
2.4.1 Breast Cancer
2.4.2 Colorectal Cancer
2.4.3 Lung Cancer
2.4.4 Prostate Cancer
2.4.5 Others
2.5 Angiogenesis Modulators Sales by Application
2.5.1 Global Angiogenesis Modulators Sale Market Share by Application (2017-2022)
2.5.2 Global Angiogenesis Modulators Revenue and Market Share by Application (2017-2022)
2.5.3 Global Angiogenesis Modulators Sale Price by Application (2017-2022)
3 GLOBAL ANGIOGENESIS MODULATORS BY COMPANY
3.1 Global Angiogenesis Modulators Breakdown Data by Company
3.1.1 Global Angiogenesis Modulators Annual Sales by Company (2020-2022)
3.1.2 Global Angiogenesis Modulators Sales Market Share by Company (2020-2022)
3.2 Global Angiogenesis Modulators Annual Revenue by Company (2020-2022)
3.2.1 Global Angiogenesis Modulators Revenue by Company (2020-2022)
3.2.2 Global Angiogenesis Modulators Revenue Market Share by Company (2020-2022)
3.3 Global Angiogenesis Modulators Sale Price by Company
3.4 Key Manufacturers Angiogenesis Modulators Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiogenesis Modulators Product Location Distribution
3.4.2 Players Angiogenesis Modulators Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANGIOGENESIS MODULATORS BY GEOGRAPHIC REGION
4.1 World Historic Angiogenesis Modulators Market Size by Geographic Region (2017-2022)
4.1.1 Global Angiogenesis Modulators Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Angiogenesis Modulators Annual Revenue by Geographic Region
4.2 World Historic Angiogenesis Modulators Market Size by Country/Region (2017-2022)
4.2.1 Global Angiogenesis Modulators Annual Sales by Country/Region (2017-2022)
4.2.2 Global Angiogenesis Modulators Annual Revenue by Country/Region
4.3 Americas Angiogenesis Modulators Sales Growth
4.4 APAC Angiogenesis Modulators Sales Growth
4.5 Europe Angiogenesis Modulators Sales Growth
4.6 Middle East & Africa Angiogenesis Modulators Sales Growth
5 AMERICAS
5.1 Americas Angiogenesis Modulators Sales by Country
5.1.1 Americas Angiogenesis Modulators Sales by Country (2017-2022)
5.1.2 Americas Angiogenesis Modulators Revenue by Country (2017-2022)
5.2 Americas Angiogenesis Modulators Sales by Type
5.3 Americas Angiogenesis Modulators Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiogenesis Modulators Sales by Region
6.1.1 APAC Angiogenesis Modulators Sales by Region (2017-2022)
6.1.2 APAC Angiogenesis Modulators Revenue by Region (2017-2022)
6.2 APAC Angiogenesis Modulators Sales by Type
6.3 APAC Angiogenesis Modulators Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Angiogenesis Modulators by Country
7.1.1 Europe Angiogenesis Modulators Sales by Country (2017-2022)
7.1.2 Europe Angiogenesis Modulators Revenue by Country (2017-2022)
7.2 Europe Angiogenesis Modulators Sales by Type
7.3 Europe Angiogenesis Modulators Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angiogenesis Modulators by Country
8.1.1 Middle East & Africa Angiogenesis Modulators Sales by Country (2017-2022)
8.1.2 Middle East & Africa Angiogenesis Modulators Revenue by Country (2017-2022)
8.2 Middle East & Africa Angiogenesis Modulators Sales by Type
8.3 Middle East & Africa Angiogenesis Modulators Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiogenesis Modulators
10.3 Manufacturing Process Analysis of Angiogenesis Modulators
10.4 Industry Chain Structure of Angiogenesis Modulators
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiogenesis Modulators Distributors
11.3 Angiogenesis Modulators Customer
12 WORLD FORECAST REVIEW FOR ANGIOGENESIS MODULATORS BY GEOGRAPHIC REGION
12.1 Global Angiogenesis Modulators Market Size Forecast by Region
12.1.1 Global Angiogenesis Modulators Forecast by Region (2023-2028)
12.1.2 Global Angiogenesis Modulators Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiogenesis Modulators Forecast by Type
12.7 Global Angiogenesis Modulators Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Celgene Corporation (USA)
13.1.1 Celgene Corporation (USA) Company Information
13.1.2 Celgene Corporation (USA) Angiogenesis Modulators Product Offered
13.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Celgene Corporation (USA) Main Business Overview
13.1.5 Celgene Corporation (USA) Latest Developments
13.2 Eisai (Japan)
13.2.1 Eisai (Japan) Company Information
13.2.2 Eisai (Japan) Angiogenesis Modulators Product Offered
13.2.3 Eisai (Japan) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eisai (Japan) Main Business Overview
13.2.5 Eisai (Japan) Latest Developments
13.3 Amgen, Inc. (USA)
13.3.1 Amgen, Inc. (USA) Company Information
13.3.2 Amgen, Inc. (USA) Angiogenesis Modulators Product Offered
13.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Amgen, Inc. (USA) Main Business Overview
13.3.5 Amgen, Inc. (USA) Latest Developments
13.4 Genentech, Inc. (USA)
13.4.1 Genentech, Inc. (USA) Company Information
13.4.2 Genentech, Inc. (USA) Angiogenesis Modulators Product Offered
13.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Genentech, Inc. (USA) Main Business Overview
13.4.5 Genentech, Inc. (USA) Latest Developments
13.5 GlaxoSmithKline plc (UK)
13.5.1 GlaxoSmithKline plc (UK) Company Information
13.5.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Offered
13.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline plc (UK) Main Business Overview
13.5.5 GlaxoSmithKline plc (UK) Latest Developments
13.6 Bayer Pharma AG (Germany)
13.6.1 Bayer Pharma AG (Germany) Company Information
13.6.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Offered
13.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bayer Pharma AG (Germany) Main Business Overview
13.6.5 Bayer Pharma AG (Germany) Latest Developments
13.7 Bionomics Ltd. (Australia)
13.7.1 Bionomics Ltd. (Australia) Company Information
13.7.2 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Offered
13.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bionomics Ltd. (Australia) Main Business Overview
13.7.5 Bionomics Ltd. (Australia) Latest Developments
13.8 CASI Pharmaceuticals, Inc. (USA)
13.8.1 CASI Pharmaceuticals, Inc. (USA) Company Information
13.8.2 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Offered
13.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CASI Pharmaceuticals, Inc. (USA) Main Business Overview
13.8.5 CASI Pharmaceuticals, Inc. (USA) Latest Developments
13.9 AstraZeneca plc (UK)
13.9.1 AstraZeneca plc (UK) Company Information
13.9.2 AstraZeneca plc (UK) Angiogenesis Modulators Product Offered
13.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AstraZeneca plc (UK) Main Business Overview
13.9.5 AstraZeneca plc (UK) Latest Developments
13.10 Eli Lilly and Company (USA)
13.10.1 Eli Lilly and Company (USA) Company Information
13.10.2 Eli Lilly and Company (USA) Angiogenesis Modulators Product Offered
13.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eli Lilly and Company (USA) Main Business Overview
13.10.5 Eli Lilly and Company (USA) Latest Developments
13.11 F.Hoffmann-La Roche AG (Switzerland)
13.11.1 F.Hoffmann-La Roche AG (Switzerland) Company Information
13.11.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Offered
13.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 F.Hoffmann-La Roche AG (Switzerland) Main Business Overview
13.11.5 F.Hoffmann-La Roche AG (Switzerland) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Angiogenesis Modulators Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Angiogenesis Modulators Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Angiogenesis Inhibitors
Table 4. Major Players of Angiogenesis Stimulators
Table 5. Major Players of Angiogenin
Table 6. Major Players of Others
Table 7. Global Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 8. Global Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 9. Global Angiogenesis Modulators Revenue by Type (2017-2022) & ($ million)
Table 10. Global Angiogenesis Modulators Revenue Market Share by Type (2017-2022)
Table 11. Global Angiogenesis Modulators Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 13. Global Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 14. Global Angiogenesis Modulators Revenue by Application (2017-2022)
Table 15. Global Angiogenesis Modulators Revenue Market Share by Application (2017-2022)
Table 16. Global Angiogenesis Modulators Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Angiogenesis Modulators Sales by Company (2020-2022) & (K MT)
Table 18. Global Angiogenesis Modulators Sales Market Share by Company (2020-2022)
Table 19. Global Angiogenesis Modulators Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Angiogenesis Modulators Revenue Market Share by Company (2020-2022)
Table 21. Global Angiogenesis Modulators Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Angiogenesis Modulators Producing Area Distribution and Sales Area
Table 23. Players Angiogenesis Modulators Products Offered
Table 24. Angiogenesis Modulators Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Angiogenesis Modulators Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Angiogenesis Modulators Sales Market Share Geographic Region (2017-2022)
Table 29. Global Angiogenesis Modulators Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Angiogenesis Modulators Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Angiogenesis Modulators Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Angiogenesis Modulators Sales Market Share by Country/Region (2017-2022)
Table 33. Global Angiogenesis Modulators Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Angiogenesis Modulators Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 36. Americas Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 37. Americas Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 39. Americas Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 40. Americas Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 41. Americas Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 42. Americas Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 43. APAC Angiogenesis Modulators Sales by Region (2017-2022) & (K MT)
Table 44. APAC Angiogenesis Modulators Sales Market Share by Region (2017-2022)
Table 45. APAC Angiogenesis Modulators Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Angiogenesis Modulators Revenue Market Share by Region (2017-2022)
Table 47. APAC Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 48. APAC Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 49. APAC Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 50. APAC Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 51. Europe Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 52. Europe Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 53. Europe Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 55. Europe Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 56. Europe Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 57. Europe Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 58. Europe Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Angiogenesis Modulators
Table 68. Key Market Challenges & Risks of Angiogenesis Modulators
Table 69. Key Industry Trends of Angiogenesis Modulators
Table 70. Angiogenesis Modulators Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Angiogenesis Modulators Distributors List
Table 73. Angiogenesis Modulators Customer List
Table 74. Global Angiogenesis Modulators Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Angiogenesis Modulators Sales Market Forecast by Region
Table 76. Global Angiogenesis Modulators Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Angiogenesis Modulators Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Angiogenesis Modulators Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Angiogenesis Modulators Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Angiogenesis Modulators Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Angiogenesis Modulators Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Angiogenesis Modulators Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Angiogenesis Modulators Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Angiogenesis Modulators Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Angiogenesis Modulators Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Angiogenesis Modulators Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Angiogenesis Modulators Revenue Market Share Forecast by Application (2023-2028)
Table 94. Celgene Corporation (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 95. Celgene Corporation (USA) Angiogenesis Modulators Product Offered
Table 96. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. Celgene Corporation (USA) Main Business
Table 98. Celgene Corporation (USA) Latest Developments
Table 99. Eisai (Japan) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 100. Eisai (Japan) Angiogenesis Modulators Product Offered
Table 101. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. Eisai (Japan) Main Business
Table 103. Eisai (Japan) Latest Developments
Table 104. Amgen, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Amgen, Inc. (USA) Angiogenesis Modulators Product Offered
Table 106. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Amgen, Inc. (USA) Main Business
Table 108. Amgen, Inc. (USA) Latest Developments
Table 109. Genentech, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 110. Genentech, Inc. (USA) Angiogenesis Modulators Product Offered
Table 111. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. Genentech, Inc. (USA) Main Business
Table 113. Genentech, Inc. (USA) Latest Developments
Table 114. GlaxoSmithKline plc (UK) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Offered
Table 116. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline plc (UK) Main Business
Table 118. GlaxoSmithKline plc (UK) Latest Developments
Table 119. Bayer Pharma AG (Germany) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Offered
Table 121. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. Bayer Pharma AG (Germany) Main Business
Table 123. Bayer Pharma AG (Germany) Latest Developments
Table 124. Bionomics Ltd. (Australia) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 125. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Offered
Table 126. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 127. Bionomics Ltd. (Australia) Main Business
Table 128. Bionomics Ltd. (Australia) Latest Developments
Table 129. CASI Pharmaceuticals, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 130. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Offered
Table 131. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 132. CASI Pharmaceuticals, Inc. (USA) Main Business
Table 133. CASI Pharmaceuticals, Inc. (USA) Latest Developments
Table 134. AstraZeneca plc (UK) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 135. AstraZeneca plc (UK) Angiogenesis Modulators Product Offered
Table 136. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 137. AstraZeneca plc (UK) Main Business
Table 138. AstraZeneca plc (UK) Latest Developments
Table 139. Eli Lilly and Company (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 140. Eli Lilly and Company (USA) Angiogenesis Modulators Product Offered
Table 141. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 142. Eli Lilly and Company (USA) Main Business
Table 143. Eli Lilly and Company (USA) Latest Developments
Table 144. F.Hoffmann-La Roche AG (Switzerland) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 145. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Offered
Table 146. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 147. F.Hoffmann-La Roche AG (Switzerland) Main Business
Table 148. F.Hoffmann-La Roche AG (Switzerland) Latest Developments
Table 1. Angiogenesis Modulators Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Angiogenesis Modulators Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Angiogenesis Inhibitors
Table 4. Major Players of Angiogenesis Stimulators
Table 5. Major Players of Angiogenin
Table 6. Major Players of Others
Table 7. Global Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 8. Global Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 9. Global Angiogenesis Modulators Revenue by Type (2017-2022) & ($ million)
Table 10. Global Angiogenesis Modulators Revenue Market Share by Type (2017-2022)
Table 11. Global Angiogenesis Modulators Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 13. Global Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 14. Global Angiogenesis Modulators Revenue by Application (2017-2022)
Table 15. Global Angiogenesis Modulators Revenue Market Share by Application (2017-2022)
Table 16. Global Angiogenesis Modulators Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Angiogenesis Modulators Sales by Company (2020-2022) & (K MT)
Table 18. Global Angiogenesis Modulators Sales Market Share by Company (2020-2022)
Table 19. Global Angiogenesis Modulators Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Angiogenesis Modulators Revenue Market Share by Company (2020-2022)
Table 21. Global Angiogenesis Modulators Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Angiogenesis Modulators Producing Area Distribution and Sales Area
Table 23. Players Angiogenesis Modulators Products Offered
Table 24. Angiogenesis Modulators Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Angiogenesis Modulators Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Angiogenesis Modulators Sales Market Share Geographic Region (2017-2022)
Table 29. Global Angiogenesis Modulators Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Angiogenesis Modulators Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Angiogenesis Modulators Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Angiogenesis Modulators Sales Market Share by Country/Region (2017-2022)
Table 33. Global Angiogenesis Modulators Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Angiogenesis Modulators Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 36. Americas Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 37. Americas Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 39. Americas Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 40. Americas Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 41. Americas Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 42. Americas Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 43. APAC Angiogenesis Modulators Sales by Region (2017-2022) & (K MT)
Table 44. APAC Angiogenesis Modulators Sales Market Share by Region (2017-2022)
Table 45. APAC Angiogenesis Modulators Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Angiogenesis Modulators Revenue Market Share by Region (2017-2022)
Table 47. APAC Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 48. APAC Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 49. APAC Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 50. APAC Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 51. Europe Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 52. Europe Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 53. Europe Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 55. Europe Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 56. Europe Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 57. Europe Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 58. Europe Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Angiogenesis Modulators Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Angiogenesis Modulators Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Angiogenesis Modulators Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Angiogenesis Modulators Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Angiogenesis Modulators
Table 68. Key Market Challenges & Risks of Angiogenesis Modulators
Table 69. Key Industry Trends of Angiogenesis Modulators
Table 70. Angiogenesis Modulators Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Angiogenesis Modulators Distributors List
Table 73. Angiogenesis Modulators Customer List
Table 74. Global Angiogenesis Modulators Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Angiogenesis Modulators Sales Market Forecast by Region
Table 76. Global Angiogenesis Modulators Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Angiogenesis Modulators Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Angiogenesis Modulators Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Angiogenesis Modulators Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Angiogenesis Modulators Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Angiogenesis Modulators Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Angiogenesis Modulators Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Angiogenesis Modulators Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Angiogenesis Modulators Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Angiogenesis Modulators Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Angiogenesis Modulators Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Angiogenesis Modulators Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Angiogenesis Modulators Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Angiogenesis Modulators Revenue Market Share Forecast by Application (2023-2028)
Table 94. Celgene Corporation (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 95. Celgene Corporation (USA) Angiogenesis Modulators Product Offered
Table 96. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. Celgene Corporation (USA) Main Business
Table 98. Celgene Corporation (USA) Latest Developments
Table 99. Eisai (Japan) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 100. Eisai (Japan) Angiogenesis Modulators Product Offered
Table 101. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. Eisai (Japan) Main Business
Table 103. Eisai (Japan) Latest Developments
Table 104. Amgen, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 105. Amgen, Inc. (USA) Angiogenesis Modulators Product Offered
Table 106. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Amgen, Inc. (USA) Main Business
Table 108. Amgen, Inc. (USA) Latest Developments
Table 109. Genentech, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 110. Genentech, Inc. (USA) Angiogenesis Modulators Product Offered
Table 111. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. Genentech, Inc. (USA) Main Business
Table 113. Genentech, Inc. (USA) Latest Developments
Table 114. GlaxoSmithKline plc (UK) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Offered
Table 116. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline plc (UK) Main Business
Table 118. GlaxoSmithKline plc (UK) Latest Developments
Table 119. Bayer Pharma AG (Germany) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 120. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Offered
Table 121. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. Bayer Pharma AG (Germany) Main Business
Table 123. Bayer Pharma AG (Germany) Latest Developments
Table 124. Bionomics Ltd. (Australia) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 125. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Offered
Table 126. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 127. Bionomics Ltd. (Australia) Main Business
Table 128. Bionomics Ltd. (Australia) Latest Developments
Table 129. CASI Pharmaceuticals, Inc. (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 130. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Offered
Table 131. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 132. CASI Pharmaceuticals, Inc. (USA) Main Business
Table 133. CASI Pharmaceuticals, Inc. (USA) Latest Developments
Table 134. AstraZeneca plc (UK) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 135. AstraZeneca plc (UK) Angiogenesis Modulators Product Offered
Table 136. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 137. AstraZeneca plc (UK) Main Business
Table 138. AstraZeneca plc (UK) Latest Developments
Table 139. Eli Lilly and Company (USA) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 140. Eli Lilly and Company (USA) Angiogenesis Modulators Product Offered
Table 141. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 142. Eli Lilly and Company (USA) Main Business
Table 143. Eli Lilly and Company (USA) Latest Developments
Table 144. F.Hoffmann-La Roche AG (Switzerland) Basic Information, Angiogenesis Modulators Manufacturing Base, Sales Area and Its Competitors
Table 145. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Offered
Table 146. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 147. F.Hoffmann-La Roche AG (Switzerland) Main Business
Table 148. F.Hoffmann-La Roche AG (Switzerland) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Angiogenesis Modulators
Figure 2. Angiogenesis Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiogenesis Modulators Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Angiogenesis Modulators Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Angiogenesis Modulators Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Angiogenesis Inhibitors
Figure 10. Product Picture of Angiogenesis Stimulators
Figure 11. Product Picture of Angiogenin
Figure 12. Product Picture of Others
Figure 13. Global Angiogenesis Modulators Sales Market Share by Type in 2021
Figure 14. Global Angiogenesis Modulators Revenue Market Share by Type (2017-2022)
Figure 15. Angiogenesis Modulators Consumed in Breast Cancer
Figure 16. Global Angiogenesis Modulators Market: Breast Cancer (2017-2022) & (K MT)
Figure 17. Angiogenesis Modulators Consumed in Colorectal Cancer
Figure 18. Global Angiogenesis Modulators Market: Colorectal Cancer (2017-2022) & (K MT)
Figure 19. Angiogenesis Modulators Consumed in Lung Cancer
Figure 20. Global Angiogenesis Modulators Market: Lung Cancer (2017-2022) & (K MT)
Figure 21. Angiogenesis Modulators Consumed in Prostate Cancer
Figure 22. Global Angiogenesis Modulators Market: Prostate Cancer (2017-2022) & (K MT)
Figure 23. Angiogenesis Modulators Consumed in Others
Figure 24. Global Angiogenesis Modulators Market: Others (2017-2022) & (K MT)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Figure 26. Global Angiogenesis Modulators Revenue Market Share by Application in 2021
Figure 27. Angiogenesis Modulators Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Angiogenesis Modulators Revenue Market Share by Company in 2021
Figure 29. Global Angiogenesis Modulators Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Angiogenesis Modulators Revenue Market Share by Geographic Region in 2021
Figure 31. Global Angiogenesis Modulators Sales Market Share by Region (2017-2022)
Figure 32. Global Angiogenesis Modulators Revenue Market Share by Country/Region in 2021
Figure 33. Americas Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 34. Americas Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 35. APAC Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 36. APAC Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 37. Europe Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 38. Europe Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 40. Middle East & Africa Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 41. Americas Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 42. Americas Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 43. United States Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Angiogenesis Modulators Sales Market Share by Region in 2021
Figure 48. APAC Angiogenesis Modulators Revenue Market Share by Regions in 2021
Figure 49. China Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 56. Europe Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 57. Germany Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 64. Egypt Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Angiogenesis Modulators in 2021
Figure 70. Manufacturing Process Analysis of Angiogenesis Modulators
Figure 71. Industry Chain Structure of Angiogenesis Modulators
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 1. Picture of Angiogenesis Modulators
Figure 2. Angiogenesis Modulators Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiogenesis Modulators Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Angiogenesis Modulators Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Angiogenesis Modulators Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Angiogenesis Inhibitors
Figure 10. Product Picture of Angiogenesis Stimulators
Figure 11. Product Picture of Angiogenin
Figure 12. Product Picture of Others
Figure 13. Global Angiogenesis Modulators Sales Market Share by Type in 2021
Figure 14. Global Angiogenesis Modulators Revenue Market Share by Type (2017-2022)
Figure 15. Angiogenesis Modulators Consumed in Breast Cancer
Figure 16. Global Angiogenesis Modulators Market: Breast Cancer (2017-2022) & (K MT)
Figure 17. Angiogenesis Modulators Consumed in Colorectal Cancer
Figure 18. Global Angiogenesis Modulators Market: Colorectal Cancer (2017-2022) & (K MT)
Figure 19. Angiogenesis Modulators Consumed in Lung Cancer
Figure 20. Global Angiogenesis Modulators Market: Lung Cancer (2017-2022) & (K MT)
Figure 21. Angiogenesis Modulators Consumed in Prostate Cancer
Figure 22. Global Angiogenesis Modulators Market: Prostate Cancer (2017-2022) & (K MT)
Figure 23. Angiogenesis Modulators Consumed in Others
Figure 24. Global Angiogenesis Modulators Market: Others (2017-2022) & (K MT)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Application (2017-2022)
Figure 26. Global Angiogenesis Modulators Revenue Market Share by Application in 2021
Figure 27. Angiogenesis Modulators Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Angiogenesis Modulators Revenue Market Share by Company in 2021
Figure 29. Global Angiogenesis Modulators Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Angiogenesis Modulators Revenue Market Share by Geographic Region in 2021
Figure 31. Global Angiogenesis Modulators Sales Market Share by Region (2017-2022)
Figure 32. Global Angiogenesis Modulators Revenue Market Share by Country/Region in 2021
Figure 33. Americas Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 34. Americas Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 35. APAC Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 36. APAC Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 37. Europe Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 38. Europe Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Angiogenesis Modulators Sales 2017-2022 (K MT)
Figure 40. Middle East & Africa Angiogenesis Modulators Revenue 2017-2022 ($ Millions)
Figure 41. Americas Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 42. Americas Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 43. United States Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Angiogenesis Modulators Sales Market Share by Region in 2021
Figure 48. APAC Angiogenesis Modulators Revenue Market Share by Regions in 2021
Figure 49. China Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 56. Europe Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 57. Germany Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Angiogenesis Modulators Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Angiogenesis Modulators Revenue Market Share by Country in 2021
Figure 64. Egypt Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Angiogenesis Modulators Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Angiogenesis Modulators in 2021
Figure 70. Manufacturing Process Analysis of Angiogenesis Modulators
Figure 71. Industry Chain Structure of Angiogenesis Modulators
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
